* Evolent Health Inc EVH.N reported quarterly adjusted
earnings
of 59 cents per share for the quarter ended in September. The
mean expectation of nine analysts for the quarter was
for earnings of 12 cents per share.
* Revenue rose 58.5% to $352.59 million from a year ago;
analysts
expected $356.77 million.
* Evolent Health Inc's reported EPS for the quarter was 2
cents.
* The mean earnings estimate of analysts had risen by
about 16.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Evolent Health Inc shares had fallen by 19.5% this
quarter and
gained 4.6% so far this year.
* The company reported quarterly net income of $2.12
million.
* Wall Street's median 12-month price target for Evolent
Health
Inc is $45.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
2 at 10:06 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.12 0.59 Beat
Jun. 30 2022 0.05 0.10 Beat
Mar. 31 2022 0.00 0.12 Beat
Dec. 31 2021 0.01 0.08 Beat